ServicesCommercial Services & SuppliesTrading & Distributors

Evoq Remedies Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 16 filings·Updated 15 Oct 2026
Showing 10 of 16 filings.
15 Oct 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms processing of dematerialisation requests, listing of securities, and cancellation of physical certificates

Dematerialisation status

  • Dematerialisation requests were processed within the prescribed time limit.
  • Dematerialised securities have been listed on the stock exchanges.
  • Physical certificates received for dematerialisation were mutilated and cancelled after verification, with depository name substituted as registered owner.
Filed 14:46View Source
30 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Evoq Remedies Limited — Trading window closed from 1st October, 2026 till 48 hours after the declaration and publication of Unaudited Financial Results for the Half Year ended 30th September, 2026.

Evoq Remedies Limited — Trading window closed from 1st October, 2026 till 48 hours after the declaration and publication of Unaudited Financial Results for the Half Year ended 30th September, 2026.

Filed 17:16View Source
30 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Intimation of Closure of Trading Window

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 11:31View Source
6 Jan 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of certificate of Reg74(5) of SEBI (Depositories and participants) Regulations, 2018 for the Quarter ended on 31st December 2025

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 12:34View Source
24 Oct 20251 filing
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:20View Source
23 Oct 20252 filings
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 14:52View Source
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Patel

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 09:13View Source
10 Oct 20252 filings
Company UpdateGeneral

Integrated Filling (Finance)

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:54View Source
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 11:33View Source
9 Oct 20251 filing
Company UpdateBoard Meeting Rescheduled

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 ,inter alia, to consider and approve With reference to our earlier ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 13:34View Source
Showing 10 of 16 filings